Published in Rev Infect Dis on October 24, 1985
Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals. J Exp Med (1987) 1.56
Molecular typing of Salmonella typhi strains from Dhaka (Bangladesh) and development of DNA probes identifying plasmid-encoded multidrug-resistant isolates. J Clin Microbiol (1996) 1.37
Molecular analysis of environmental and human isolates of Salmonella typhi. Appl Environ Microbiol (1996) 1.13
Outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast. Eur J Epidemiol (2005) 0.97
New advances in the diagnosis of typhoid and detection of typhoid carriers. Malays J Med Sci (2000) 0.80
Typhoid fever from water desalinized using reverse osmosis. Epidemiol Infect (1995) 0.79
Pathogenesis of Escherichia coli diarrhea. N Engl J Med (1971) 10.36
Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet (1978) 10.29
Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis (1974) 6.38
Typhoid fever: pathogenesis and immunologic control. N Engl J Med (1970) 4.95
Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet (1975) 4.85
Fecal leukocytes in diarrheal illness. Ann Intern Med (1972) 3.89
Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis (1989) 3.71
Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45
Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. J Infect Dis (1974) 2.73
Suppressive activity of mefloquine in sporozoite-induced human malaria. Antimicrob Agents Chemother (1976) 2.71
Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med (1970) 2.63
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57
Adverse effect of lomotil therapy in shigellosis. JAMA (1973) 2.57
Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop Med Hyg (1979) 2.51
Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infect Immun (1977) 2.49
Aerogenic immunization of man with live Tularemia vaccine. Bacteriol Rev (1966) 2.42
Immunity to enterotoxigenic Escherichia coli. Infect Immun (1979) 2.30
Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis (1972) 2.29
Invasive Escherichia coli. J Infect Dis (1978) 2.19
Influenza antibody in human respiratory secretions after subcutaneous or respiratory immunization with inactivated virus. Nature (1968) 2.10
Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1974) 2.08
The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bull N Y Acad Med (1971) 2.07
Histopathology of the upper small intestines in typhoid fever. Biopsy study of experimental disease in man. Am J Dig Dis (1966) 1.97
The response of man to virulent Shigella flexneri 2a. J Infect Dis (1969) 1.97
Studies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochloride. JAMA (1968) 1.93
Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine. J Immunol (1969) 1.91
Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci (1973) 1.84
Immunity in typhoid fever: evaluation of live streptomycin-dependent vaccine. Antimicrob Agents Chemother (Bethesda) (1970) 1.82
Treatment of falciparum malaria caused by strain resistant to quinine. JAMA (1970) 1.81
Clinical approach to infectious diarrheas. Medicine (Baltimore) (1973) 1.75
Cutaneous responses to cholera skin toxin in man. I. Responses in unimmunized American males. J Infect Dis (1972) 1.74
BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1975) 1.61
Lack of enhanced oxygen consumption by polymorphonuclear leukocytes on phagocytosis of virulent Salmonella typhi. Science (1972) 1.44
Genetic susceptibility to cholera. Ann Hum Biol (1980) 1.44
Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1. J Clin Invest (1976) 1.43
Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route. Am J Epidemiol (1969) 1.42
Peptic ulcer disease: a bacterial infection? N Engl J Med (1987) 1.41
Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. J Infect Dis (1973) 1.39
Immunity in shigellosis. I. Response of man to attenuated strains of Shigella. J Infect Dis (1972) 1.39
Efficacy of a live oral cholera vaccine in human volunteers. Dev Biol Stand (1976) 1.37
Q fever hepatitis. Ann Intern Med (1971) 1.34
The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity. Ann Intern Med (1974) 1.33
Long-term Shigella-carrier state. N Engl J Med (1973) 1.32
Comparative pyrogenic reactivity of rabbit and man to bacterial endotoxin. Proc Soc Exp Biol Med (1969) 1.29
Sources of contamination in open heart surgery. JAMA (1974) 1.29
An endogenous mediator of depression of amino acids and trace metals in serum during typhoid fever. J Infect Dis (1972) 1.26
Evaluation of amantadine hydrochloride in the treatment of A2 influenzal disease. Bull World Health Organ (1969) 1.26
Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever. J Infect Dis (1975) 1.24
Studies with a new generation of oral attenuated shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri. J Infect Dis (1977) 1.22
Antimalarial effects of tetracyclines in man. J Trop Med Hyg (1971) 1.19
Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans. Infect Immun (1974) 1.18
Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines. Am J Epidemiol (1972) 1.18
Recent studies on live tularemia vaccine. Med Ann Dist Columbia (1967) 1.15
Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: potential deleterious effects of lyophilization. J Infect Dis (1976) 1.15
On the demonstration of circulating human endogenous pyrogen. Proc Soc Exp Biol Med (1972) 1.14
Typhoid fever vaccine--yes or no? Med Clin North Am (1967) 1.14
Mucociliary function during experimentally induced rhinovirus infection in man. Ann Otol Rhinol Laryngol (1973) 1.13
Evaluation of therapeutic efficacy of amantadine in patients with naturally occurring A2 influenza. JAMA (1970) 1.12
Appraisal of typhoid vaccine in experimentally infected human subjects. Trans Am Clin Climatol Assoc (1967) 1.10
Comparative efficacy of chloramphenicol, ampicillin, and co-trimoxazole in the treatment of typhoid fever. Lancet (1976) 1.09
Detection of a leukocytic endogenous mediator-like mediator of serum amino acid and zinc depression during various infectious illnesses. Infect Immun (1975) 1.09
Cholera, non-vibrio cholera, and stomach acid. Lancet (1978) 1.07
Studies of immunity in typhoid fever. Protection induced by killed oral antigens or by primary infection. Bull World Health Organ (1971) 1.06
The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera. Trans R Soc Trop Med Hyg (1979) 1.06
Analysis of infections acquired by the severely injured patient. Surg Gynecol Obstet (1973) 1.06
Cannabis, hypochlorhydria, and cholera. Lancet (1978) 1.05
Infection in the severely traumatized patient. Ann Surg (1974) 1.05
The role of endotoxin during typhoid fever and tularemia in man. IV. The integrity of the endotoxin tolerance mechanisms during infection. J Clin Invest (1969) 1.05
Lactulose therapy in Shigella carrier state and acute dysentery. Antimicrob Agents Chemother (1975) 1.04
Oral tularemia vaccine in man. Antimicrob Agents Chemother (Bethesda) (1966) 1.03
Low-Temperature-Adapted Influenza A2/AA/6/60 Virus Vaccine in Man. Infect Immun (1973) 1.03
Alice strain live attenuated influenza (H3N2) vaccin in an elderly population. Am J Epidemiol (1975) 1.02
Diarrheal diseases. Dis Mon (1969) 1.00
Duodenal isolation of Salmonella typhi by string capsule in acute typhoid fever. J Clin Microbiol (1976) 0.99
On the pathogenesis of typhoid fever. Arch Intern Med (1978) 0.98
Tularemia epidemic--Vermont, 1968. N Engl J Med (1969) 0.98
Immunization against typhoid fever. Annu Rev Med (1979) 0.98
Failure of a 3-substituted triazinoindole in the prevention of experimental human rhinovirus infection. Chemotherapy (1973) 0.98
Study of induced typhoid fever in man. I. Evaluation of vaccine effectiveness. Trans Assoc Am Physicians (1966) 0.96
Tryptophan metabolism during infectious illness in man. J Infect Dis (1970) 0.95
Infecting dose and severity of typhoid: analysis of volunteer data and examination of the influence of the definition of illness used. Epidemiol Infect (1995) 0.95
Whole-blood amino acids in experimentally induced typhoid fever in man. N Engl J Med (1968) 0.94
Reactogenicity and immunogenicity of parenteral monovalent influenza A/Victoria/3/75 (H3N2) virus vaccine in healthy adults. J Infect Dis (1977) 0.94
Enterotoxic diarrheal syndromes. Annu Rev Med (1973) 0.93
Specific microbial infections of the myocardium and pericardium. A study of 82 patients. Arch Intern Med (1967) 0.92
Cellular inflammatory responses of man to bacterial endotoxin: a comparison with PPD and other bacterial antigens. J Immunol (1972) 0.92
Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1977) 0.89
The nature of endotoxin tolerance. Trans Am Clin Climatol Assoc (1975) 0.89
Oral vaccination against tularemia in the monkeys. Proc Soc Exp Biol Med (1969) 0.89
Clinical evaluation of live, oral types 1, 2, and 5 adenovirus vaccines. Am Rev Respir Dis (1974) 0.89
Evaluation of chloramphenicol acid succinate therapy of induced typhoid fever and rocky mountain spotted fever. N Engl J Med (1970) 0.88
Mechanisms of endotoxin tolerance with special reference to man. J Infect Dis (1973) 0.87
Campylobacter pylori: its role in gastritis and peptic ulcer disease. Curr Clin Top Infect Dis (1989) 0.85
Serum zinc, iron, and copper concentrations during typhoid fever in man: effect of chloramphenicol therapy. Clin Chem (1975) 0.84
Fecal steroids in diarrhea. I. Acute shigellosis. Am J Clin Nutr (1976) 0.84
Evaluation of the efficacy of ascorbic acid in prophylaxis of induced rhinovirus 44 infection in man. J Infect Dis (1973) 0.82
Cyclooctylamine in the prevention of experimental human influenza. JAMA (1972) 0.82
Evaluation of antibiotics in a typhoid model. Antimicrob Agents Chemother (Bethesda) (1966) 0.82